Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting...
Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the...
Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion PRESS RELEASE - 22 November 2023, 10:00 CET...
Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting...
Press release Biocartis Group NV: Announcement regarding Enforcement by Secured Creditors PRESS RELEASE REGULATED INFORMATION 31 October...
Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology...
Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio PRESS RELEASE 16...
Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS...
Press Release Biocartis Group NV: Disclosure of transparency notification PRESS RELEASE: REGULATED INFORMATION ...
Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down...
Press release Biocartis Group NV: Biocartis 2023 half-year results webcast on 26 September 2023 PRESS RELEASE REGULATED INFORMATION ...
Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders PRESS RELEASE: 28 August...
Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023 PRESS RELEASE: 24 August 2023, 07:00 CEST...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.